Maynard, Mass., May 17, 2013—Allegro Diagnostics today announced its participation in the American Thoracic Society International Conference, being held May 17-22, 2013 in Philadelphia. Duncan Whitney, Ph.D., Senior Vice President, Research, Development and Technical Operations, is presenting Poster #K43, entitled “Analytical Validation of BronchoGen™, An RT-PCR Gene-Expression Test To Improve The Diagnosis of Bronchoscopy For Lung Cancer” during the Molecular Mechanisms of Carcinogenesis Poster Session on Tuesday, May 21 from 8:15 a.m. to 4:30 p.m. in Area K (Halls C-D, 200 Level) of the Pennsylvania Convention Center. During the viewing, Dr. Whitney will present results of recent studies to develop and optimize prediction accuracy in a gene expression test for lung cancer.
Dr. Whitney and Avrum Spira, M.D., Professor of Medicine and Chief of the Division of Computation Biomedicine at Boston University School of Medicine, as well as a co-founder of Allegro Diagnostics, will also be available to answer questions about the clinical trials and development of BronchoGen in the Allegro Diagnostics booth (#1442) on Tuesday, May 21.
Also, on May 18, 2013, Michael D. Webb, President and CEO of Allegro Diagnostics, will present “Commercializing a Novel Molecular Diagnostic Test in Pulmonology” at the 2013 Spring Scientific Symposium of the American Association for Bronchology and Interventional Pulmonology, being held at the Hospital of University of Pennsylvania in Philadelphia.
About the Allegro Platform